Table 2.
Predicting BARQ AUC Scores: Univariate Analyses.
| 3-Day AUC | 30-day AUC | 365-day AUC | |||||
|---|---|---|---|---|---|---|---|
| Variable | β | 95% CI | β | 95% CI | β | 95% CI | |
| Age | −0.002 | −0.004, 0.001 | −0.002 | −0.004, 0.001 | −0.001 | −0.004, 0.002 | |
| Gender | Male (0) vs. Female (1) | −0.05 | −0.12, 0.03 | −0.06 | −0.14, 0.01 | −0.04 | −0.13, 0.05 |
| Race | Non-Caucasian (0) vs. Caucasian (1) | −0.001 | −0.10, 0.10 | −0.02 | −0.12, 0.08 | −0.003 | −0.10, 0.10 |
| Ethnicity | Non-Hispanic (0) vs. Hispanic (1) | 0.06 | −0.07, 0.18 | −0.01 | −0.12, 0.15 | −0.04 | −0.09, 0.17 |
| Sexual Orientation | Heterosexual (0) vs. Non-heterosexual (1) | 0.03 | −0.08, 0.15 | 0.07 | −0.06, 0.19 | 0.11 | −0.02, 0.25 |
| Past Opioid Use | 0.10 | 0.03, 0.16 | 0.09 | 0.02, 0.17 | 0.11 | 0.03, 0.19 | |
| SOAPP-R | Low (0) vs. High (1) | 0.18 | 0.12, 0.25 | 0.21 | 0.14, 0.27 | 0.23 | 0.16, 0.30 |
| Education | −0.05 | −0.09, −0.003 | −0.06 | −0.10, −0.01 | −0.07 | −0.13, −0.02 | |
| Income | −0.02 | −0.04, 0.005 | −0.02 | −0.04, 0.005 | −0.02 | −0.04, 0.002 | |
| Duration of Chronic Pain | 0.02 | −0.05, 0.10 | 0.04 | −0.02, 0.11 | 0.06 | −0.003, 0.13 | |
| Last Pain VAS | 0.03 | 0.01, 0.05 | 0.03 | 0.01, 0.05 | 0.02 | 0.003, 0.04 | |
| Usual Pain VAS | 0.03 | 0.01, 0.04 | 0.03 | 0.01, 0.05 | 0.03 | 0.01, 0.05 | |
| PHQ-2 | Total | 0.04 | 0.02, 0.06 | 0.04 | 0.02, 0.06 | 0.06 | 0.03, 0.08 |
| GAD-7 | Total | 0.01 | 0.005, 0.02 | 0.01 | 0.006, 0.02 | 0.01 | 0.008, 0.02 |
| PCS | Total | 0.005 | 0.002, 0.01 | 0.03 | 0.01, 0.04 | 0.03 | 0.02, 0.05 |
| ISI | Total | 0.01 | 0.008, 0.02 | 0.01 | 0.01, 0.02 | 0.01 | 0.01, 0.02 |
| Number Pain Dx | 0.02 | 0.006, 0.04 | 0.02 | 0.001, 0.04 | 0.03 | 0.004, 0.05 | |
| BPI | Interference | 0.04 | 0.02, 0.05 | 0.04 | 0.02, 0.05 | 0.04 | 0.03, 0.06 |
| BPI (Primary) | Worst | 0.03 | 0.02, 0.04 | 0.03 | 0.02, 0.05 | 0.03 | 0.02, 0.05 |
| Least | 0.02 | 0.005, 0.03 | 0.01 | 0.00, 0.03 | 0.01 | −0.003, 0.03 | |
| Average | 0.04 | 0.01, 0.06 | 0.03 | 0.01, 0.05 | 0.03 | 0.01, 0.06 | |
| Current | 0.03 | 0.01, 0.04 | 0.03 | 0.01, 0.04 | 0.03 | 0.01, 0.04 | |
| Severity | 0.04 | 0.02, 0.06 | 0.03 | 0.02, 0.05 | 0.03 | 0.02, 0.05 | |
| BIS-11 | Attentional | 0.01 | 0.001, 0.02 | 0.01 | 0.002, 0.02 | 0.01 | 0.003, 0.02 |
| Motor | 0.01 | 0.004, 0.02 | 0.01 | 0.006, 0.02 | 0.02 | 0.01, 0.03 | |
| Non-planning | 0.01 | 0.004, 0.02 | 0.01 | 0.006, 0.02 | 0.01 | 0.006, 0.02 | |
Univariate analysis for demographic and self-report measures used as predictors in multivariate GLM model building. Columns are divided by proposed time of complete pain relief. Abbreviations: BARQ Benefit vs. Addiction Risk Questionnaire (BARQ); Confidence Interval (CI); Screener and Opioid Assessment for Patients in Pain-Revised (SOAPP-R); Visual Analogue Scale (VAS); Brief Pain Index (BPI); Patient Health Questionnaire 2 (PHQ-2); Generalized Anxiety Disorder 7 item scale (GAD-7); Pain Catastrophizing Scale (PCS); Insomnia Severity Index (ISI); Diagnosis (Dx); Barratt Impulsiveness Scale version 11 (BIS-11); area under the curve (AUC). p <.05. p<0.10.